MedTrace Logo

Applying Wolbachia to Eliminate Dengue

NCT03055585 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8173

Last updated 2020-06-09

No results posted yet for this study

Summary

This cluster randomised trial will evaluate the efficacy of Wolbachia-infected Aedes aegytpi mosquitoes in reducing dengue cases in Yogyakarta City, Indonesia

Conditions

  • Dengue
  • Zika Virus Infection
  • Chikungunya Fever

Interventions

BIOLOGICAL

Wolbachia-infected Aedes aegypti mosquitoes

Deployment of Wolbachia-infected Aedes aegypti mosquitoes

OTHER

standard practice dengue control

standard practice dengue control activities conducted by dengue control program

Sponsors & Collaborators

  • Monash University

    collaborator OTHER

  • The Tahija Foundation

    collaborator UNKNOWN

  • Gadjah Mada University

    lead OTHER

Principal Investigators

  • Adi Utarini, MD, PhD · Faculty of Medicine, Universitas Gadjah Mada

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-08
Primary Completion
2020-03-18
Completion
2020-04-08

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03055585 on ClinicalTrials.gov